BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

645 related articles for article (PubMed ID: 9625383)

  • 1. Cytokine activity in cancer-related anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate.
    Mantovani G; Macciò A; Lai P; Massa E; Ghiani M; Santona MC
    Semin Oncol; 1998 Apr; 25(2 Suppl 6):45-52. PubMed ID: 9625383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine involvement in cancer anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate on cytokine downregulation and improvement of clinical symptoms.
    Mantovani G; Macciò A; Lai P; Massa E; Ghiani M; Santona MC
    Crit Rev Oncog; 1998; 9(2):99-106. PubMed ID: 9973244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticytokine approaches to the treatment of anorexia and cachexia.
    Haslett PA
    Semin Oncol; 1998 Apr; 25(2 Suppl 6):53-7. PubMed ID: 9625384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized phase III clinical trial of five different arms of treatment for patients with cancer cachexia: interim results.
    Mantovani G; Macciò A; Madeddu C; Gramignano G; Serpe R; Massa E; Dessì M; Tanca FM; Sanna E; Deiana L; Panzone F; Contu P; Floris C
    Nutrition; 2008 Apr; 24(4):305-13. PubMed ID: 18262758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life and stimulation of weight gain after treatment with megestrol acetate: correlation between cytokine levels and nutritional status, appetite in geriatric patients with wasting syndrome.
    Yeh S; Wu SY; Levine DM; Parker TS; Olson JS; Stevens MR; Schuster MW
    J Nutr Health Aging; 2000; 4(4):246-51. PubMed ID: 11115810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokines and cancer anorexia cachexia syndrome.
    Bennani-Baiti N; Davis MP
    Am J Hosp Palliat Care; 2008; 25(5):407-11. PubMed ID: 18403577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Croatian guidelines for use of eicosapentaenoic acid and megestrol acetate in cancer cachexia syndrome].
    Krznarić Z; Juretić A; Samija M; Dintinjana RD; Vrdoljak E; Samarzija M; Kolacek S; Vrbanec D; Prgomet D; Ivkić M; Zelić M;
    Lijec Vjesn; 2007 Dec; 129(12):381-6. PubMed ID: 18383739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical studies on the treatment of cancer cachexia with megestrol acetate plus thalidomide.
    Wen HS; Li X; Cao YZ; Zhang CC; Yang F; Shi YM; Peng LM
    Chemotherapy; 2012; 58(6):461-7. PubMed ID: 23406994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of the cancer anorexia-cachexia syndrome: a critical reappraisal.
    Lelli G; Montanari M; Gilli G; Scapoli D; Antonietti C; Scapoli D
    J Chemother; 2003 Jun; 15(3):220-5. PubMed ID: 12868546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medroxyprogesterone acetate reduces the in vitro production of cytokines and serotonin involved in anorexia/cachexia and emesis by peripheral blood mononuclear cells of cancer patients.
    Mantovani G; Macciò A; Esu S; Lai P; Santona MC; Massa E; Dessì D; Melis GB; Del Giacco GS
    Eur J Cancer; 1997 Apr; 33(4):602-7. PubMed ID: 9274442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort.
    Jatoi A; Rowland K; Loprinzi CL; Sloan JA; Dakhil SR; MacDonald N; Gagnon B; Novotny PJ; Mailliard JA; Bushey TI; Nair S; Christensen B;
    J Clin Oncol; 2004 Jun; 22(12):2469-76. PubMed ID: 15197210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pro-inflammatory cytokines and oxidative stress/antioxidant parameters characterize the bio-humoral profile of early cachexia in lung cancer patients.
    Fortunati N; Manti R; Birocco N; Pugliese M; Brignardello E; Ciuffreda L; Catalano MG; Aragno M; Boccuzzi G
    Oncol Rep; 2007 Dec; 18(6):1521-7. PubMed ID: 17982639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Feeding-related disorders in medicine, with special reference to cancer anorexia-cachexia syndrome].
    Inui A
    Rinsho Byori; 2006 Oct; 54(10):1044-51. PubMed ID: 17133993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy (recombinant interleukin 2), hormone therapy (medroxyprogesterone acetate) and antioxidant agents as combined maintenance treatment of responders to previous chemotherapy.
    Mantovani G; Maccio A; Madeddu C; Massa E; Mudu MC; Mulas C; Gramignano G; Massidda S; Murgia V; Lusso MR; Mura L
    Int J Oncol; 2001 Feb; 18(2):383-91. PubMed ID: 11172608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of megestrol acetate on anorexia, weight loss and cachexia in cancer and AIDS patients (review).
    Strang P
    Anticancer Res; 1997; 17(1B):657-62. PubMed ID: 9066597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The incidence and pathogenesis of cancer anorexia-cachexia syndrome in lung cancer].
    Kosacka M; Weryńska B; Gołecki M; Jankowska R; Passowicz-Muszyńska E
    Pneumonol Alergol Pol; 2008; 76(5):360-5. PubMed ID: 19003767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New strategies for tumor-related cachexia].
    HNO; 1997 Nov; 45(11 Suppl):1-8. PubMed ID: 9509016
    [No Abstract]   [Full Text] [Related]  

  • 18. Medroxyprogesterone acetate in the management of cancer cachexia.
    Madeddu C; Macciò A; Panzone F; Tanca FM; Mantovani G
    Expert Opin Pharmacother; 2009 Jun; 10(8):1359-66. PubMed ID: 19445562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental cancer cachexia: the role of host-derived cytokines interleukin (IL)-6, IL-12, interferon-gamma, and tumor necrosis factor alpha evaluated in gene knockout, tumor-bearing mice on C57 Bl background and eicosanoid-dependent cachexia.
    Cahlin C; Körner A; Axelsson H; Wang W; Lundholm K; Svanberg E
    Cancer Res; 2000 Oct; 60(19):5488-93. PubMed ID: 11034092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic management of anorexia/cachexia.
    Ottery FD; Walsh D; Strawford A
    Semin Oncol; 1998 Apr; 25(2 Suppl 6):35-44. PubMed ID: 9625382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.